How persistent organic pollutants affect gut health: findings on metabolic disruptions and microbiota changes

Any metal contamination in pharmaceutical products is a huge problem. First and foremost, there are possible safety implications for patients that may ingest contaminates. For

Gilead has now passed on two biotech buy­out op­tions that it forged in sum­mer 2020. The large drug­mak­er will not ac­quire Tizona Ther­a­peu­tics, a fel­low

Re­neo Phar­ma­ceu­ti­cals’ stock plunged by 82% as it re­vealed plans to slash 70% of its work­force af­ter its on­ly drug can­di­date dis­ap­point­ed in a reg­is­tra­tional